Skip to main content
Premium Trial:

Request an Annual Quote

Movers & Shakers: Jan 15, 2009


Eksigent this week announced that Remco van Soest has been promoted to vice president of product management.

Van Soest has been with Eksigent for almost three years, beginning first as product manager then director of product management for the NanoLC product line. In his new position, he will be responsible for management and strategy development for all of Eksigent's product lines, including a soon-to-be-released chip-based LC platform

Van Soest has more than 15 years of experience in the development and application of nano HPLC instruments, the company said in a statement.

Cyntellect this week announced the appointment of Stella Redpath as director of product marketing for the company's cell health product line, and Baggi Somasundaram as product marketing manager for the company's cell purification product line.

Redpath had been a senior marketing manager at Millipore. She also has held business and sales positions at GE Healthcare and at Ciphergen Biosystems, now called Vermillion.

Somasundaram had been product manager at BD Biosciences and held business and sales positions at Atto Biosciences and at PerkinElmer.

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.